Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

Will Sunshine Heart Get Schooled If Enrollment Disappoints Again?

Sunshine Heart (NASDAQ:SSH) shares have taken a beating since their fall 2013 peak, falling about 60% from their peak on a combination of slow pivotal trial enrollment and a sharp turn away from risky, speculative health care stocks. With Sunshine Heart due to report results tomorrow (May 13), it is a safe bet that investors will be keenly focused on the enrollment figures for the COUNTER-HF study, even though it may be too optimistic to assume that the company's awareness efforts have had a major impact at this point.

A Common Problem, But One Without Easy Solutions

Sunshine Heart has definitely had some challenges getting patients enrolled in its COUNTER-HF study; the study that the company needs to...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details